带状疱疹后神经痛电针治疗失败预测模型的回顾性队列分析
本研究基于2010至2017年243例接受至少两次电针治疗的带状疱疹后神经痛成人患者,构建临床预测模型以筛选适合电针者并判断两次治疗后的预后。治疗失败率为20.6%,预测因子包括糖尿病、卡马西平使用及高初始NRS评分;模型ROC曲线下面积第一次治疗后为0.80、第三次后为0.88。
要点
- 糖尿病、使用卡马西平及高初始NRS评分是电针治疗失败的预测因素。
- 该模型首次治疗后AUC为0.80,第三次治疗后AUC为0.88。
- 研究人群治疗失败率为20.6%,可作为临床参考基线。
核心结论
- 成功开发并内部验证了带状疱疹后神经痛患者电针治疗失败的临床预测模型,有望辅助个体化选例和早期预测疗效。
研究设计与样本
- 回顾性观察性队列分析,纳入2010至2017年确诊带状疱疹后神经痛且至少接受两次电针治疗的成人患者243例。
主要发现
- 243例患者中治疗失败率为20.6%。
- 治疗失败的关键预测因素为合并糖尿病、使用卡马西平及高初始NRS评分。
- 预测模型第一次治疗后ROC曲线下面积为0.80,第三次治疗后为0.88。
关键数值与推荐
- 治疗成功以数字评分量表(NRS)定义,失败为NRS评分>3。
- 预测建模与内部验证采用bootstrap重抽样。
临床怎么用
- 可依据糖尿病、卡马西平使用及初始NRS评分识别电针治疗失败风险较高的带状疱疹后神经痛患者。
- 模型可在治疗早期(首次治疗后AUC 0.80、第三次后0.88)辅助预判电针疗效。
局限性
- 为回顾性观察性队列分析,仅进行内部验证,未报告外部验证结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postherpetic neuralgia (PHN) is a prevalent and painful complication following herpes zoster infection, impacting patient quality of life and posing significant treatment challenges. Current pharmacological approaches often result in adverse effects. The aim of this study was to develop a clinical prediction model for selecting PHN patients for electroacupuncture (EA) treatment and to determine the prognostic outcomes after two sessions. METHODS: We conducted a retrospective observational cohort analysis on adults diagnosed with PHN between 2010 and 2017. All participants had undergone at least two acupuncture sessions. Data analysis included demographic, clinical and treatment variables to identify predictors of treatment outcomes. Treatment success was defined using the numeric rating scale (NRS), with failure characterized by an NRS score >3. Predictive modeling and internal validation employed bootstrap resampling. RESULTS: Among 243 patients included in the study, the treatment failure rate was 20.6%. Key predictive factors for treatment outcome were the presence of diabetes mellitus, use of carbamazepine and high initial NRS scores. The accuracy of the prediction model was reflected by an area under the receiver operating characteristic (ROC) curve of 0.80 after the first session and 0.88 following the third session, indicating a robust predictive capability. CONCLUSION: In this study, we successfully developed and internally validated a clinical prediction model for EA in PHN patients. We anticipate that this model may guide clinicians in personalized patient care, optimizing the selection process for EA treatment, and predicting treatment response early in the treatment cycle.
引用
- Lawanaskol S, Ruengwongroj P, Paecharoen S, et al. Prediction of acupuncture treatment failure in patients with postherpetic neuralgia: a retrospective observational cohort analysis. Acupunct Med. 2026. PMID: 42178141. doi:10.1177/09645284261444375
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。